Parameters & Coverage
Live Update
Headset Hardware Cost
$2,200
Insurance Coverage / HRA
20%
Monthly Pad Refills ($20/mo)
$20/mo
Pharmacotherapy / Therapy Baseline
Monthly Rx Medication Co-pay
$45
Monthly Therapy Session Co-pays
$160
Financing Horizon
12 Months
Calculations reflect verified out-of-pocket medical amortizations.
Break-Even Horizon
Month 10
Net 12-Month Savings
$460
Headset 12M Out-of-Pocket
$2,000
Alternative 12M Expenses
$2,460
Status: cost-effective at month 10
68% symptom reduction
Cumulative Out-of-Pocket Expenditure (USD)
Flow tDCS
Rx & Therapy
Clinical Trial Trajectory: PHQ-9 Depression Severity Index (0-27)
Clinical Benchmark: Double-blind RCT data demonstrates that at 6 to 10 weeks of active frontal tDCS (2mA, left dorsolateral prefrontal cortex anodal excitation), 68% of participants experience clinically significant symptom reduction or complete remission.
Simulated 30-Minute tDCS Protocol Session
Current: 2.0 mAFrequency (Weeks 1-3)
5 Sessions / Week
Maintenance (Week 4+)
2 Sessions / Week
Contact Impedance
Optimal (< 15 kΩ)
Pad Refill & Maintenance: Each session uses medical-grade saline-soaked single-use pads placed at F3 (Anode) and FP2 (Cathode) targeting the dorsolateral prefrontal cortex to restore cortical activity.